Kaempferol’s promise in fighting triple-negative breast cancer

FHS
July 24, 2024
10:23 pm

Review highlights kaempferol’s potential in treating triple-negative breast cancer through various anticancer mechanisms and improving chemotherapeutic efficacy.

Study identifies hormonal and reproductive factors for rheumatoid arthritis in women

Early menopause-;before the age of 45-;taking hormone replacement therapy (HRT), and having 4 or more children are among several hormonal and reproductive factors linked to

January 10, 2024

Bridging the Gap: Health Equity, Cancer Screening, and the Role of FQHCs

Jonathan Govette, Founder and CEO of Oatmeal Health The Persistent Challenge of Healthcare Access and Cancer Screening Disparities In the United States, the healthcare landscape

July 23, 2024

Roivant unveils its next deal, hoping for TL1A-sized potential from a shelved Bayer lung disease therapy

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

September 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.